Supplementary MaterialsFile S1. a female with pre\existing medullary thyroid carcinoma who

Supplementary MaterialsFile S1. a female with pre\existing medullary thyroid carcinoma who exhibited no significant adjustments in serum calcitonin amounts despite treatment with dulaglutide 2.0 mg for six months in the Assessment of Weekly AdministRation of LY2189265 [dulaglutide] in Diabetes\5 clinical study (NCT00734474). Case statement Elevated serum calcitonin was mentioned inside a 56\yr\old female with Type… Continue reading Supplementary MaterialsFile S1. a female with pre\existing medullary thyroid carcinoma who